NOTTINGHAM, England & RESEARCH TRIANGLE PARK, N.C., May 14, 2026--Worldwide Clinical Trials ("Worldwide"), a global contract ...
Bria-PROS+ is BriaCell’s next generation personalized off-the-shelf immunotherapy for prostate cancerImmune stimulating ...
Major operational milestone achieved as Incannex advances late-stage development of IHL-42X, with all clinical sites identified and trial infrastructure activated ...
R3 Stem Cell, a top regenerative medicine company, announced the publication of a systematic review by its Research ...
Northeast Community College’s paramedicine program continues to prepare students for high-demand careers in emergency medical ...
Empagliflozin and dapagliflozin show similar effectiveness in preventing cardiorenal outcomes among patients with type 2 ...
Former Hospice RN Turns Years of Memory Care Experience Into Two Family Guides Spring Hill, United States - May 11, ...
Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center registrational trial for SENTI-202, building off the strong Phase 1 clinical results demonstrating deep a ...
ERS urges uniform training, equitable therapy access and harmonized data systems to cut respiratory health disparities amid aging populations and environmental threats.
A South Shields cancer survivor lived without a working boiler for more than a year - until a visit from local firefighters ...
A foundation in California has donated $2 million to boost heart and cancer research at Atrium Health. The money from the ...
Many, but not all, people experience withdrawal symptoms when they stop taking an S.S.R.I. or other antidepressant; for some, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results